IP Library › Assignment 017164/0276
Patent Assignment
Reel/Frame 017164/0276

Security Agreement

Recorded: 2006-02-14 Received: 2006-02-14 Pages: 25
Assignor
HUMANETICS CORPORATION
Executed: 2005-04-21
Assignee
WHITEBOX ADVISORS, LLC, AS COLLATERAL AGENT
3033 EXCELSIOR BOULEVARD, SUITE 300, MINNEAPOLIS, MN, 55416, UNITED STATES
Covered Properties (18)
Method of achieving accelerated weight loss by administration of a weight loss accelerating agent to a dieting mammal
Application: 10/541,781 →
Composition and Method of Promoting Weight Loss, Fat Loss or Modulation of Metabolic Rate
Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
Application: 10/541,780 →
Multiple temperature hot water dispensing system
Application: 60/604,627 →
Composition containing 7-oxo DHEA, a source of bioavailable chromium, a source of bioavailable calcium, green tea extract and vitamins C & D, and method of promoting weight loss, fat loss or modulation of a dieting-induced change in basal metabolic rate by administration of the composition
Application: 60/599,469 →
System and Method for Pushing Information from a Host System to a Mobile Data Communication Device
Application: 10/893,455 →
Method of Achieving Accelerated Weight Loss by Administration of a Weight Loss Accelerating Agent to a Dieting Mammal
Method of Achieving Accelerated Fat Loss by Administration of a Fat Loss Accelerating Agent to a Dieting Mammal
Treatment of Chronic Fatigue Syndrome and Fibromyalgia Syndrome
Application: 10/433,043 →
Use of DELTA5-Androstene-3BETA-Ol-7,17-Dione in the Treatment of Lupus Erythematosus
Application: 10/431,960 →
Method of Modulating the Basal Metabolic Rate of a Dieting Mammal by Administration of a Metabolic Modulating Agent to the Dieting Mammal
Application: 10/340,980 →
Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
Application: 60/439,816 →
Integrated photoelectrochemical cell and system having a liquid electrolyte
Application: 60/429,753 →
Use of DELTA5-Androstene-3BETA Ol-7,17-Dione in the Treatment of Lupus Erythematosus
Application: 10/106,580 →
Treatment of Chronic Fatigue Syndrome and Fibromyalgia Syndrome by the Administration of DELTA5- Androstene- 3BETA-Ol-7, 17 Dione and Metabolizable Precursors Thereof
Treatment of Dermatitis by the Topical Application of DELTA5-Androstene-3BETA-Ol-7,17 Dione and Metabolizable Precursors Thereof
Application: 09/805,024 →
Method for Diminishing Wrinkles and Fine Lines of the Skin by the Topical Application of DELTA5-Androstene-3BETA-Ol-7, 17 Dione and Metabolizable Precursors Thereof
Application: 09/799,295 →
Method of Moisturizing the Skin by the Topical Application of DELTA5-Androstene-3BETA-Ol-7,17 Dione and Metabolizable Precursors Thereof
Application: 09/799,313 →